Table 3.
Relation between clinicopathological parameter and SBF2-AS1 expression of BC patients
| Clinicopathological parameter | SBF2-AS1 | P value | ||
|---|---|---|---|---|
| High expression (n = 39) | Low expression (n = 11) | |||
| Age (years) | ||||
| < 50 | 29 | 24 | 5 | 0.491 |
| ≥ 50 | 21 | 15 | 6 | |
| Histological type | ||||
| Ductal | 45 | 36 | 9 | 0.167 |
| Lobular | 2 | 1 | 2 | |
| Other | 3 | 2 | 1 | |
| Histological grade | ||||
| I | 14 | 10 | 4 | 0.142 |
| II | 26 | 23 | 3 | |
| III | 10 | 6 | 4 | |
| Lymph node metastasis | ||||
| YES | 20 | 12 | 8 | 0.012 |
| NO | 30 | 27 | 3 | |
| TNM stage | ||||
| I | 4 | 3 | 1 | 0.977 |
| II | 36 | 28 | 8 | |
| III | 10 | 8 | 2 | |
| Tumor size | ||||
| < 2 cm | 19 | 10 | 9 | 0.001 |
| ≥ 2 cm | 31 | 29 | 2 | |
| Clinical stage | ||||
| I | 5 | 1 | 4 | 0.004 |
| II | 28 | 24 | 4 | |
| III | 17 | 14 | 3 | |